Glucose metabolism during the acute prostate cancer treatment trajectory: The influence of age and obesity

Article ID	Journal	Published Year	Pages	File Type
8586968	Clinical Nutrition	2018	9 Pages	PDF

Abstract

At baseline patients with aggressive prostate cancer demonstrated impaired glucose tolerance compared with men of similar age and body size. Following treatment, glucose tolerance improved in the absence of changes in expected modifiers of glucose metabolism. These improvements may be related to treatment.

Keywords

IGF HDL DBP FFM SBP PSA HOMA-IR IGF-1 RIA OGTT QUICKI SMI IGFBP 1-RM SMM TNF ADT 1 repetition maximum AUC c-Peptide high-density lipoprotein Oral glucose tolerance test Prostate specific antigen insulin interleukin cardiovascular disease Triglycerides Skeletal muscle mass fat mass Fat Free Mass Body composition androgen deprivation therapy radioimmunoassay CVD Prostate cancer body mass index BMI Skeletal muscle index quantitative insulin sensitivity check index Insulin-like growth factor tumor necrosis factor diastolic blood pressure systolic blood pressure Low-density lipoprotein LDL Homeostatic model of insulin resistance Young males area under the curve Radiation therapy insulin-like growth factor binding protein C-reactive protein CRP